PTEN loss and PI3K/Akt pathway activation in melanoma are associated with resistance to T cell-mediated tumor killing, reduced T cell infiltration at tumor sites, likely due to increased secretion of immunosuppressive cytokines by cancer cells, and resistance to immune checkpoint inhibitors (94). The gene discussed is PIK3CA; the disease is cancer.